Literature DB >> 6300186

Improvements in obtaining and characterizing mouse cerebrospinal fluid. Application to mouse hepatitis virus-induced encephalomyelitis.

J O Fleming, J Y Ting, S A Stohlman, L P Weiner.   

Abstract

This report describes advances in techniques for analyzing cellular and humoral immune components in the cerebrospinal fluid (CSF) of the mouse that are applicable to other laboratory animals. CSF studies undertaken during experimental infection of mice with JHM strain virus (JHMV) of mouse hepatitis virus are presented. A critical pitfall which can lead to erroneous or invalid results is contamination of the CSF by even minute quantities of blood. Means of avoiding this contamination are attention to anatomical reference points, the use of a micropipet, and prior intracardiac perfusion of animals with phosphate-buffered saline. Cells in the CSF were typed as either B, T, polymorphonuclear, or mononuclear cells by the combination of a microcytotoxicity assay and histologic stains. A radioimmunoassay (RIA) allowed quantification of antibodies to JHMV in the CSF and indicated the presence of intrathecal synthesis of antibody in chronically infected mice. The combined use of these sensitive methods makes possible CSF analysis in individual mice rather than in pooled groups.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300186      PMCID: PMC7172882          DOI: 10.1016/0165-5728(83)90017-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Pathogenesis of visna. IV. Spinal fluid studies.

Authors:  N Nathanson; G Petursson; G Georgsson; P A Palsson; J R Martin; A Miller
Journal:  J Neuropathol Exp Neurol       Date:  1979-05       Impact factor: 3.685

2.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

Authors:  P B MEDAWAR
Journal:  Br J Exp Pathol       Date:  1948-02

3.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

Review 4.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice.

Authors:  D E Griffin
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain.

Authors:  S A Stohlman; P R Brayton; J O Fleming; L P Weiner; M M Lai
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

8.  Chronic central nervous system demyelination in mice after JHM virus infection.

Authors:  S A Stohlman; L P Weiner
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

9.  Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.

Authors:  S A Stohlman; J A Frelinger; L P Weiner
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

10.  Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  21 in total

1.  Spread of herpes simplex virus to the cerebrospinal fluid and the meninges in experimental mouse encephalitis.

Authors:  R H Boerman; A C Peters; B R Bloem; A K Raap; M van der Ploeg
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

3.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.

Authors:  M A Sussman; R A Shubin; S Kyuwa; S A Stohlman
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

6.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Protective effects of BDNF overexpression bone marrow stromal cell transplantation in rat models of traumatic brain injury.

Authors:  Zhitao Wang; Weifeng Yao; Quanjun Deng; Xiaohui Zhang; Jianning Zhang
Journal:  J Mol Neurosci       Date:  2012-11-11       Impact factor: 3.444

8.  Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice.

Authors:  Min Liu; David G Kuhel; Ling Shen; David Y Hui; Stephen C Woods
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-29       Impact factor: 3.619

9.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

10.  Epidermal growth factor does not cross the blood-brain barrier.

Authors:  K A Nave; R Probstmeier; M Schachner
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.